Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Pierre Fabre pursues its commitment against rare diseases in the pediatric, oncology and dermatology fields.
2023-02-06 18:00
Qurient Co. Ltd. and TB Alliance Announce Exclusive License Agreement for Telacebec (Q203), a New Anti-Tuberculosis Agent
2023-02-03 14:34
Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short
2023-01-31 21:30
Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic
2023-01-31 16:10
Chula Medicine Reveals Detection of Latent Dementia
2023-01-30 11:01
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
2023-01-18 21:00
CGTN: China's COVID-19 vaccines proven safe, effective by trials and data
2023-01-17 23:50
CGTN: China protects lives, shares experience in global COVID-19 fight
2023-01-16 07:29
CGTN: TCM continues to play significant role in treating COVID-19
2023-01-11 23:09
CGTN: China downgrades COVID-19 rules as nation readies for normal life
2023-01-09 10:42
China welcomes first arrivals following downgraded COVID management
2023-01-09 07:40
CGTN: China's preparedness for adjusting its COVID-19 policies
2023-01-05 04:07
CGTN: China's dynamic zero-COVID policy sets the foundation for reopening
2023-01-05 04:05
China's optimization of control measures lays solid foundation for COVID-19 response
2023-01-04 15:39
Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company
2023-01-03 16:00
CGTN: China monitors coronavirus mutations to adjust COVID-19 response
2023-01-03 08:27
CGTN: Xi Jinping salutes ordinary people's extraordinary efforts in New Year Address
2023-01-03 07:52
CGTN:How do emergency wards in China cope with increasing COVID patients?
2023-01-03 06:54
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates
2022-12-30 21:00
Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19
2022-12-30 13:23
1
4
5
6
7
8
71